Caveolin-1 antibody | knockout validation | Cell Signaling 3267

This is a knockout-validated antibody summary, based on the publication "Glucocorticoid-mediated induction of caveolin-1 disrupts cytoskeletal organization, inhibits cell migration and re-epithelialization of non-healing wounds", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Caveolin-1 antibody | knockout validation | Cell Signaling 3267 figure 1
Figure 1. Western blotting of the indicated proteins in human keratinocytes expressing endogenous levels of Cav1 (WT) and Cav1-knockout cells (Cav1KO). From [1].
Antibody information

Rabbit monoclonal IgG

Company: Cell Signaling

Antibody: Caveolin-1

Catalog number: 3267

Summary: Rabbit monoclonal antibody against a synthetic peptide corresponding to residues surrounding Glu20 of human caveolin-1. Reacts with human, mouse, rat, hamster, monkey, bovine, and dog. Suitable for western blot, immunoprecipitation, immunohistochemistry (paraffin and frozen), immunofluorescence/immunocytochemistry and flow cytometry (fixed/permeabilized).

Validation Method

Western blot

Sample

WT and Cav1-knockout HaCaT cells.

Blocking agent

TBS, 0.1% Tween20, 5% BSA for 1 h.

Primary incubation

1:2,000 dilution overnight.

Secondary incubation

1:1,000 dilution anti-rabbit IgG HRP (Cell Signaling, #7074).

References
  1. Jozic I, Abujamra B, Elliott M, Wikramanayake T, Marjanovic J, Stone R, et al. Glucocorticoid-mediated induction of caveolin-1 disrupts cytoskeletal organization, inhibits cell migration and re-epithelialization of non-healing wounds. Commun Biol. 2021;4:757 pubmed publisher